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Abstract: A new polymer brush was synthesized by spontaneous polymerization of benzofulvene 
macromonomer 6-MOEG-9-T-BF3k bearing a nona(ethylene glycol) side chain linked to the 
3-phenylindene scaffold by means of a triazole heterocycle. The polymer structure was studied by 
SEC-MALS, NMR spectroscopy, and MALDI-TOF MS techniques, and the results supported the 
role of oligomeric initiatory species in the spontaneous polymerization of polybenzofulvene 
derivatives. The aggregation features of high molecular weight poly-6-MOEG-9-T-BF3k-FE were 
investigated by pyrene fluorescence analysis, dynamic light scattering studies, and transmission 
electron microscopy, which suggested a tendency towards the formation of spherical objects 
showing dimensions in the range of 20–200 nm. Moreover, poly-6-MOEG-9-T-BF3k-FE showed an 
interesting cytocompatibility in the whole concentration range tested that, besides its aggregation 
features, makes this polybenzofulvene brush a good polymer candidate for nanoencapsulation and 
delivery of drug molecules. Finally, the photo-physical features of poly-6-MOEG-9-T-BF3k-FE 
could allow the biodistribution of the resulting drug delivery systems to be monitored by 
fluorescence microscopy techniques. 
Keywords: PEGylation; grafting through; polybenzofulvene; nanocarrier; drug delivery systems; 
spontaneous polymerization; affinity polymerization 
 
1. Introduction 
Molecular brushes, polymer brushes, or cylindrical brushes are the most common names to 
designate a very intriguing large class of polymers obtained by dense grafting of polymeric side 
chains onto linear polymeric backbones [1,2]. The interesting features of this unique family of 
macromolecules are determined in a large part by side chain features such as length, 
physico-chemical properties, and grafting density. Furthermore, the conformational behavior of 
backbone and side chains can be affected by solvent properties, temperature, pH, and ionic strength 
so that polymer brushes (PB) can show macromolecular features sensitive to the surrounding 
environment [3]. They can be synthesized by means of three different procedures [3]: (a) grafting 
through (GT, macromonomer polymerizations) [4]; (b) grafting onto (GO, insertion of side chains 
Pharmaceutics 2019, 11, 444 2 of 22 
 
onto polymeric backbones) [5]; and (c) grafting from (polymerization of side chains from a 
macroinitiator backbone) [6]. 
Around two decades ago, we discovered the spontaneous polymerization of benzofulvene 
derivative BF1 (in the apparent absence of catalysts or initiators by evaporation of the solvent) and 
started a large program of synthetic and characterization studies, which led to the development of 
the large family of polybenzofulvene derivatives. These studies suggested for most of the 
synthesized polymers a vinyl structure stabilized by aromatic stacking interactions [7–13] and led to 
the obtainment of interesting materials showing remarkable optoelectronic features [14–21]. 
By grafting monomethyl oligo(ethylene glycol) (MOEG) side chains (SC) onto the 
polybenzofulvene backbone of poly-BF1 and poly-BF3, we designed and synthesized a family of 
PEGylated polybenzofulvene brushes (PPBFBs) that includes poly-2-MOEG-9-BF1 [22], 
poly-6-MOEG-9-BF3k [23], poly-6-MOEG-9-TM-BF3k [24,25], poly-4,6-MOEG-9-TM-BF3k [26], and 
poly-4′,6-MOEG-9-TM-BF3k [26] (Figure 1) [27]. 
 
Figure 1. The previously proposed aggregation mechanism in PEGylated polybenzofulvene brush 
(PPBFB) derivatives. 
Intriguingly, these PPBFB derivatives were capable of interacting with water showing different 
aggregation features, which appeared to be modulated by the presence of the MOEG SC. In 
particular, the aggregation characteristics of the PPBFB derivatives spanned from the formation of a 
compact physical hydrogel (poly-2-MOEG-9-BF1) [28] to the water solubility of 
poly-4,6-MOEG-9-TM-BF3k [26] and poly-4′,6-MOEG-9-TM-BF3k, which showed reduced 
aggregation tendency due to the presence of two MOEG-9 side chains in each monomeric unit [26]. 
The results obtained supported the important role played by the presence and the location in the 
monomeric unit of MOEG-9 SC in the aggregation behavior of these PPBFB derivatives.  
Moreover, PPBFB derivatives were used in the development of drug delivery systems (DDS) 
such as the hydrogel obtained with poly-2-MOEG-9-BF1 for the delivery of a human 
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immunoglobulin [28] and the thermoresponsive gel nanoparticles obtained with 
poly-6-MOEG-9-BF3k for the delivery of the low molecular weight peptide anticancer drug 
leuprolide [29]. 
The biocompatibility and the apparent bioresorbability features of our PPBFB stimulated the 
employment of poly-6-MOEG-9-TM-BF3k architecture in the development of a PPBFB copolymer 
(i.e., poly-6-MOEG-9-TM-BF3k-co-6-BAUP-TM-BF3k) bearing dynamic binding sites [30–32] in 
order to obtain a macromolecule capable of loading the anticancer drug doxorubicin and releasing 
the drug to cancer cells [33]. The tri-component polybenzofulvene brush TCPB was then developed 
as a third-generation PPBFB, in which the core–shell architecture was further elaborated by the 
presence of the external targeting shell [34] consisting of low molecular weight hyaluronic acid (HA) 
macromolecules [34,35]. We assumed that the HA coating of TCPB was capable of interacting with 
CD44 receptors (overexpressed in many tumor cells) and therefore mediating the targeted delivery 
of doxorubicin to tumor cells [36].  
In the aim of evaluating the role of the methylene-oxy spacer in the aggregation features of 
these PEGylated polybenzofulvene brushes, the structure of 6-MOEG-9-TM-BF3k [24] was 
manipulated by linking the triazole moiety directly to the position 6 of the indene nucleus of 
6-MOEG-9-T-BF3k (Figure 2) and the resulting benzofulvene monomer was induced to polymerize 
spontaneously in the apparent absence of initiators and/or catalyst by removal of the solvent to 
afford PPBFP derivative poly-6-MOEG-9-T-BF3k. 
 
Figure 2. Design of PPBFB poly-6-MOEG-9-T-BF3k from poly-6-MOEG-9-TM-BF3k. 
Thus as in a “grafting through” approach, the biorelevant PPBFP derivative 
poly-6-MOEG-9-T-BF3k was prepared and characterized in terms of its macromolecular structure, 
optical features, aggregation liability, and cytocompatibility characteristics. The results of these 
studies suggest a way to modulate the molecular weight distribution (MWD) and support the 
evaluation of this PEGylated polybenzofulvene brush in drug delivery applications. 
2. Materials and Methods  
2.1. Synthesis 
A Gallenkamp apparatus was used in the determination of melting points in open capillaries. 
Merck silica gel 60 (230–400 mesh) was used for column chromatography. Merck TLC plates, silica 
gel 60 F254 were used for TLC. NMR spectra were recorded with a Bruker (Karlsruhe, Germany) 
DRX-400 AVANCE or a Bruker DRX-500 AVANCE spectrometer in the indicated solvents (TMS as 
internal standard): the values of the chemical shifts are expressed in ppm and the coupling constants 
(J) in Hz. An Agilent (Santa Clara, CA, USA) 1100 LC/MSD operating with an electrospray source 
was used in mass spectrometry experiments. 
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2.1.1. Ethyl 6-[2-(trimethylsilyl)ethynyl]-1-oxo-3-phenyl-1H-indene-2-carboxylate (2) 
A mixture of triflate derivative 1 [14] (0.40 g, 0.938 mmol) in DMF (10 mL) containing 
tetrabutylammonium iodide (TBAI, 0.34 g, 0.92 mmol), Pd(PPh3)2Cl2 (0.040 g, 0.057 mmol), CuI (11 
mg, 0.058 mmol), TEA (2.0 mL, 14.3 mmol), and ethynyltrimethylsilane (137 mg, 1.39 mmol) was 
heated at 55 °C under stirring for 1.5 h. The resulting mixture was partitioned between 
dichloromethane and a saturated solution of NH4Cl. The organic layer was dried over sodium 
sulfate and evaporated under reduced pressure. Purification of the residue by flash chromatography 
with petroleum ether–ethyl acetate (95:5) as the eluent gave pure compound 2 as an orange solid 
(0.30 g, yield 85%). An analytical sample was obtained by recrystallization from ethyl acetate by 
slow evaporation at room temperature (mp 101–103 °C). 1H NMR (400 MHz, CDCl3): 0.25 (s, 9H), 
1.16 (t, J = 7.1, 3H), 4.19 (q, J = 7.1, 2H), 7.13 (d, J = 7.6, 1H), 7.47–7.50 (m, 6H), 7.66 (d, J = 1.1, 1H). MS 
(ESI): m/z 397 (M + Na+). 
2.1.2. Ethyl 6-ethynyl-1-oxo-3-phenyl-1H-indene-2-carboxylate (3) 
To a mixture of 3 (0.26 g, 0.694 mmol) in absolute ethanol (20 mL) was added a 1M solution of 
sodium ethoxide in ethanol (1.45 mL, 1.45 mmol) until the complete consumption of 3. The reaction 
mixture was then concentrated under reduced pressure and the resulting residue was partitioned 
between dichloromethane and a saturated solution of sodium chloride. After drying over sodium 
sulfate, the organic layer was dried and concentrated under reduced pressure. Purification of the 
residue by flash chromatography with petroleum ether–ethyl acetate (95:5) as the eluent gave 3 as a 
red solid (0.20 g, yield 95%). Recrystallization from ethyl acetate by slow evaporation of the solvent 
gave an analytical sample as X-ray quality red-orange crystals melting at 132–134 °C. 1H NMR (400 
MHz, CDCl3): 1.16 (t, J = 7.1, 3H), 3.22 (s, 1H), 4.20 (q, J = 7.1, 2H), 7.17 (d, J = 7.7, 1H), 7.51–7.54 (m, 
6H), 7.68 (d, J = 1.4, 1H). MS (ESI): m/z 325 (M + Na+). 
2.1.3. Ethyl 
6-[1-(2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl)-1H-1,2,3-triazol-4-yl]-1-oxo-3-phenyl-1H-inden
e-2-carboxylate (4) 
A mixture of 3 (0.19 g, 0.629 mmol) in THF (8.0 mL) containing 
28-azido-2,5,8,11,14,17,20,23,26-nonaoxaoctacosane [24] (0.14 g, 0.31 mmol), CuBr (0.011 mg, 0.077 
mmol), and DIPEA (0.014 mL, 0.080 mmol) was stirred at room temperature for 6 h. The volatile was 
then removed under reduced pressure and the residue was partitioned between dichloromethane 
and brine. The organic layer was dried over sodium sulfate and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography with ethyl acetate–methanol 
(9:1) as the eluent. The combined fractions were evaporated under reduced pressure and the residue 
was dissolved into ethyl acetate and then treated with QUADRASIL MP (100 mg). After filtration the 
solution was concentrated under reduced pressure to obtain pure compound 4 as a red-orange oil 
(0.22 g, yield 94%). 1H NMR (400 MHz, CDCl3): 1.16 (t, J = 7.1, 3H), 3.36 (s, 3H), 3.52 (m, 2H), 
3.57–3.67 (m, 30H), 3.92 (t, J = 5.0, 2H), 4.20 (q, J = 7.1, 2H), 4.60 (t, J = 4.8, 2H), 7.26 (m, 1H), 7.53 (m, 
5H), 7.95 (d, J = 1.3, 1H), 8.08 (dd, J = 7.6,1.2, 1H), 8.16 (s, 1H). MS (ESI): m/z 778 (M + Na+). 
2.1.4. Ethyl 
1-hydroxy-1-methyl-6-[1-(2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl)-1H-1,2,3-triazol-4-yl]-3-ph
enyl-1H-indene-2-carboxylate (5) 
Indenone derivative 4 (0.18 g, 0.238 mmol) was dissolved into dichloromethane (20 mL) and a 
2M solution of Al(CH3)3 in toluene (0.35 mL, 0.70 mmol) was added. The reaction mixture was 
stirred under an inert atmosphere at room temperature for 20 min, and the Al(CH3)3 excess was then 
cautiously destroyed with a 2M NaOH solution. The obtained mixture was partitioned between 
water and ethyl acetate, and the organic layer was dried over sodium sulfate and concentrated 
under reduced pressure. Purification of the residue by flash chromatography with 
dichloromethane–methanol (95:5) as the eluent afforded indenol derivative 5 as a white waxy solid 
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(0.14 g, yield 76%). 1H NMR (400 MHz, CDCl3): 1.06 (t, J = 7.0, 3H), 1.82 (s, 3H), 3.36 (s, 3H), 3.50–3.54 
(m, 2H), 3.59–3.65 (m, 30H), 3.69 (s, 1H), 3.92 (t, J = 5.0, 2H), 4.07–4.20 (m, 2H), 4.60 (t, J = 4.9, 2H), 7.20 
(d, J = 7.9, 1H), 7.36–7.47 (m, 5H), 7.87 (dd, J = 7.9,1.6, 1H), 8.00 (d, J = 1.5, 1H), 8.08 (s, 1H). MS (ESI): 
m/z 794 (M + Na+). 
2.1.5. Ethyl 
1-methylene-6-[1-(2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl)-1H-1,2,3-triazol-4-yl]-3-phenyl-1
H-indene-2-carboxylate (6-MOEG-9-T-BF3k) 
Procedure A. A mixture of indenol derivative 5 (5.0 mg, 0.00648 mmol) in CDCl3 (1.7 mL) and 
trifluoroacetic acid (TFA, 0.3 mL) containing p-toluenesulfonic acid monohydrate (PTSA, 2.0 mg, 
0.010 mmol) was refluxed for 30 min and then cooled to room temperature. The reaction mixture 
was washed with water and dried over sodium sulfate to afford a solution of monomer 
6-MOEG-9-T-BF3k that was used in the NMR studies. 1H NMR (500 MHz, CDCl3): 1.06 (t, J = 7.0, 
3H), 3.36 (s, 3H), 3.52 (m, 2H), 3.57–3.66 (m, 30H), 3.92 (t, J = 5.0, 2H), 4.14 (q, J = 7.0, 2H), 4.61 (t, J = 
5.0, 2H), 6.50 (s, 1H), 6.64 (s, 1H), 7.30 (d, J = 8.0, 1H), 7.40–7.49 (m, 5H), 7.74 (dd, J = 8.0, 1.5, 1H), 8.10 
(s, 1H), 8.27 (s, 1H); see Figure 4. 13C NMR (500 MHz, CDCl3): 13.8, 50.5, 59.0, 60.2, 69.5, 70.5, 71.9, 
117.4, 117.8, 121.4, 122.5, 125.7, 128.0, 128.3, 128.7, 130.7, 134.4, 137.6, 141.0, 143.7, 147.6, 152.6, 164.9; 
see Figure 5. 
Procedure B. A mixture of indenol derivative 5 (4.5 mg, 0.00583 mmol) in CD3CN (0.75 mL) 
containing p-toluenesulfonic acid monohydrate (0.20 mg, 0.00105 mmol) was heated at 80 °C for 14 h 
and then cooled to room temperature. The reaction mixture was filtered through a short pad of 
alumina to afford a solution of monomer 6-MOEG-9-T-BF3k that was used in the NMR studies. 1H 
NMR (500 MHz, CD3CN): 1.11 (t, J = 7.1, 3H), 3.32 (s, 3H), 3.43–3.67 (m, 32H), 3.95 (t, J = 5.1, 2H), 4.17 
(q, J = 7.1, 2H), 4.62 (t, J = 5.0, 2H), 6.62 (s, 1H), 6.65 (s, 1H), 7.36 (d, J = 7.9, 1H), 7.49–7.58 (m, 5H), 7.90 
(dd, J = 8.0, 1.5, 1H), 8.34 (s, 1H), 8.38 (d, J = 0.9, 1H); see Figure 4. 13C NMR (500 MHz, CDCl3): 13.2, 
50.2, 57.9, 60.3, 68.9, 69.9, 70.0, 70.1, 71.5, 121.9, 122.4, 125.7, 125.9, 128.2, 128.6, 128.7, 131.2, 134.0, 
137.4, 140.5, 143.8, 146.7, 151.7, 164.7; see Figure 5. 
2.1.6. Poly[ethyl 
1-methylene-6-[1-(2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl)-1H-1,2,3-triazol-4-yl]-3-phenyl-1
H-indene-2-carboxylate] (poly-6-MOEG-9-T-BF3k) 
Procedure FE. A mixture of indenol derivative 5 (0.16 g, 0.207 mmol) in CDCl3 (18 mL) and 
trifluoroacetic acid (2.0 mL) containing p-toluenesulfonic acid monohydrate (0.055 g, 0.29 mmol) was 
refluxed for 30 min and then cooled to room temperature. The resulting mixture was then washed 
with water and dried over sodium sulfate to afford a solution of monomer 6-MOEG-9-T-BF3k that 
was concentrated under reduced pressure. The resulting residue was dissolved into chloroform (10 
mL) and again evaporated (this process of dissolution/evaporation was repeated three times). The 
last residue was purified by precipitation with n-hexane from a solution of the polymer in 
chloroform–ethanol (1:1) and dried under reduced pressure to obtain poly-6-MOEG-9-T-BF3k-FE as 
a gummy pale yellow solid (0.11 g, yield 68% in monomeric unit). 1H NMR (500 MHz, CDCl3): see 
Figure 7. 13C NMR (125 MHz, CDCl3): see Figure 8. 
Procedure SE. A mixture of indenol derivative 5 (0.10 g, 0.13 mmol) in CDCl3 (10 mL) and 
trifluoroacetic acid (2.0 mL) containing p-toluenesulfonic acid monohydrate (0.036 g, 0.19 mmol) was 
heated to reflux for 30 min and then cooled to room temperature. The resulting mixture was washed 
with water and dried over sodium sulfate to afford a solution of monomer 6-MOEG-9-T-BF3k that 
was allowed to concentrate at room temperature by spontaneous evaporation of the solvent. The 
resulting residue was purified by precipitation with n-hexane from a solution of the polymer in 
dichloromethane and dried under reduced pressure to obtain poly-6-MOEG-9-T-BF3k-SE as a 
gummy pale yellow solid (0.080 g, yield 82% in monomeric unit). 1H NMR (500 MHz, CDCl3): see 
Figure 7. 13C NMR (125 MHz, CDCl3): see Figure 8. 
Procedure WA. A mixture of indenol derivative 5 (55 mg, 0.071 mmol) in dry CH3CN (10 mL) 
containing p-toluenesulfonic acid monohydrate (2.5 mg, 0.013 mmol) was heated at reflux for 30 h 
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and then cooled to room temperature. The reaction mixture was then filtered through a short pad of 
alumina to afford a solution of monomer 6-MOEG-9-T-BF3k that was diluted with water and 
concentrated under a gentle nitrogen stream. The resulting colorless mixture was extracted with 
dichloromethane and the combined organic extracts were dried over sodium sulfate and 
concentrated under reduced pressure. The resulting residue was purified by precipitation with 
n-hexane from a solution of the polymer in dichloromethane and dried under reduced pressure to 
obtain poly-6-MOEG-9-T-BF3k-WA as a gummy pale yellow solid (16 mg, yield 30% in monomeric 
unit). 1H NMR (500 MHz, CDCl3): see Figure 7. 13C NMR (125 MHz, CDCl3): see Figure 8. 
2.2. X-Ray Crystallography 
Single crystals of indenone derivative 3 were used in X-ray data collection on an 
Oxford-Diffraction Xcalibur Sapphire 3 diffractometer (Santa Clara, CA, USA) equipped with a 
graphite monochromated Mo Kα radiation (λ = 0.71073 Å) at 293 K. The direct methods 
implemented in SHELXS-2013 program were used in the solution of the structures [37]. The 
refinements were carried out by full-matrix anisotropic least-squares on F2 for all reflections for 
non-H atoms by means of the SHELXL-2018 program [38]. Crystallographic data (excluding 
structure factors) for the structure in this paper have been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publications no. CCDC 1901307. Copies of the data 
can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; 
(fax: +44 (0) 1223 336 033; or e-mail: deposit@ccdc.cam.ac.uk). 
2.3. Mass Spectrometry 
MALDI-TOF (matrix assisted laser desorption/ionization-time of flight) mass spectra were 
recorded in linear mode by means of a Bruker Ultraflex III MALDI-TOF/TOF instrument equipped 
with a Nd:YAG laser at a wavelength of 355 nm with <500 ps pulse and 200 Hz firing rate. The 
accelerating voltage was 22 kV. External calibration was performed using a Bruker calibration 
mixture consisting of polypeptides with different molar mass values. All measurements were 
performed in positive ion mode. Approximately 2000 laser shots were accumulated for each mass 
spectrum, and 2,5-dihydroxybenzoic acid was used as the matrix in the analysis of the samples. 
Mass spectra in reflectron mode were recorded by means of a 4800 Proteomic Analyzer 
(Applied Biosystems, Foster City, CA, USA) MALDI-TOF/TOF instrument equipped with a Nd:YAG 
laser at a wavelength of 355 nm with <500 ps pulse and 200 Hz firing rate. The accelerating voltage 
was 20 kV. External calibration was performed using an Applied Biosystems calibration mixture 
consisting of polypeptides with different molar mass values. The irradiance was maintained slightly 
above the threshold, to obtain a mass resolution of about 7000–10,000 fwhm; isotopic resolution was 
observed throughout the entire mass range detected (from m/z 500 up to m/z 5000). Mass accuracy 
was about 40 ppm. All measurements were performed in positive ion mode; approximately 1500 
laser shots were accumulated for each mass spectrum in reflectron mode, and 250 laser shots in 
linear one too. For the analysis of all the samples several matrices such as DHB, DCTB and dithranol, 
were used with and without salts as cationizing agent (i.e., CF3COOLi; CF3COONa). All matrices 
were solubilized in THF at a concentration of 0.1 M, poly-6-MOEG-9-T-BF3k samples were 
solubilized in the appropriate solvent (i.e., CHCl3 or DMF) with a concentration of 2 mg/mL. 
Samples for MALDI analysis were prepared by the dried-droplet method, in which a mixture of 
matrix and sample was deposited onto the target plate and dried at room temperature under inert 
atmosphere (N2 flow), and also by the multilayer method, in which firstly a layer of matrix solution 
(0.3 μL) onto the target plate then after 10 min a layer of polymer solution (0.2 μL) was deposited 
and finally after 1 h a final layer of matrix solution (0.3 μL) was added. The best spectra were 
recorded using DCTB as matrix with or without CF3COOLi as doping agent.  
2.4. SEC-MALS 
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The MWD (molecular weight distribution) characterization of the polymers was performed by 
a Wyatt MALS (Santa Barbara, CA, USA) light scattering photometer on-line to a SEC 
chromatographic system. The SEC-MALS system and the corresponding experimental conditions 
were identical to those used in our previous studies [9,22,25] and are not reported in detail here. 
2.5. Dynamic Light Scattering (DLS) Analysis and ζ Potential Measurements 
The mean diameter, width of distribution (polydispersity index, PDI), and ζ potential of the 
nanoparticles were measured at 25 °C using a Zetasizer NanoZS instrument (Worcestershire, UK) 
fitted with a 532 nm laser at fixed scattering angle of 173°. The intensity-average hydrodynamic 
diameter (size in nm) and PDI of nanosystems were characterized in double distilled water after 2 
and 20 days. Polymer dispersions were obtained at room temperature by stirring samples (0.2–2 
mg/mL) until complete dispersion (2 days). The ζ potential (mV) was calculated from the 
electrophoretic mobility using the Smoluchowsky relationship and assuming that K·a >> 1 (where K 
and a are the Debye-Hückel parameter and particle radius, respectively). Each experiment was 
performed in triplicate. 
2.6. Transmission Electron Microscopy (TEM) 
A solution of poly-6-MOEG-9-T-BF3k in water was dropped onto a 300 mesh formvar-coated 
copper grid. The sample excess was then blotted by filter paper and the grids were stained with 1% 
of aqueous uranyl acetate solution. Samples were observed in a FEI Tecnai G2 Spirit transmission 
electron microscopy (Hillsboro, OR, USA) at an acceleration voltage of 100 kV. 
2.7. Cytotoxicity Evaluation 
The cell viability was assessed by the tetrazolium salt (MTS) assay on human colon cancer 
(HCT116) and normal human bronchial epithelial (16HBE) cell lines, (purchased from Istituto 
Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna, Brescia, Italy) using a 
commercially available kit (Cell Titer 96 Aqueous One Solution Cell Proliferation assay, Promega, 
Madison, WI, USA ). Cells were seeded in 96-well plates at a density of 10 × 104 cells/well and grown 
in Dulbecco’s Minimum Essential Medium (DMEM) with 10% FBS (fetal bovine serum) and 1% of 
penicillin/streptomycin (10,000 U/mL penicillin and 10 mg/mL streptomycin) at 37 °C in 5% CO2 
humidified atmosphere. After 24 h of cell growth the medium was replaced with 200 μL of fresh 
culture medium containing poly-6-MOEG-9-T-BF3k-FE at the following concentrations per well: 
0.005, 0.01, 0.03, 0.1 and 0.5 mg/mL. Cells incubated with fresh culture medium were used as 
negative control. After 24 and 48 h of incubation time DMEM was replaced with 100 μL of fresh 
medium and 20 μL of a MTS solution was added to each well. Plates were incubated for an 
additional 2 h at 37 °C. Then, the absorbance at 490 nm was measured using a microplate reader 
(Multiskan, Thermo Fisher Scientific Oy, Vantaa, Finland). Pure cell medium was used as a negative 
control. Results were expressed as percentage reduction of the control cells. All culture experiments 
were performed in triplicates. 
For statistical analysis, a one way analysis of variance (ANOVA) was applied to compare 
different groups. Data were considered statistically significant with a value of p < 0.05 and 
differences between different groups were compared using a posteriori Bonferroni t-test. All values 
are expressed as the average of three experiments ± standard deviation. 
3. Results and Discussion 
3.1. Synthesis  
The “grafting through” approach to PPBFB derivative poly-6-MOEG-9-T-BF3k is shown in 
Scheme 1.  
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Scheme 1. “Grafting through” approach to PPBFB derivative poly-6-MOEG-9-T-BF3k. Reagents: (i) 
ethynyltrimethylsilane, CuI, Pd(PPh3)2Cl2, TBAI, TEA, DMF; (ii) C2H5ONa, C2H5OH; (iii) 
CH3(OCH2CH2)9N3, CuBr, DIPEA, THF; (iv) Al(CH3)3, CH2Cl2; (v) Procedure A: PTSA, TFA, CDCl3; 
Procedure B: PTSA, CD3CN; (vi) solvent elimination (for the details see the Materials and Methods 
section). 
Sonogashira coupling of triflate 1 [14] with trimethylsilylacetylene (Adrich) gave silyl 
derivative 2, which was promptly transformed into the corresponding acetylene derivative 3 by 
deprotection with sodium ethoxide in ethanol. After confirming the structure of 3 by 
crystallographic studies (Figure 3), this compound was employed in the CuAAC coupling with 
MOEG-9 chains bearing an azide group [24] in the presence of CuBr and DIPEA to obtain indenone 
derivative 4. 
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Figure 3. Structure of indenone derivative 3 found by crystallography. Ellipsoids enclose 50% 
probability. 
As expected, alkylation of indenone derivative 4 with trimethylaluminium gave indenol 5, 
which was dehydrated in chloroform (CDCl3, CH3CN, or CD3CN) in the presence of 
p-toluenesulfonic acid (PTSA) in order to obtain monomer 6-MOEG-9-T-BF3k. This benzofulvene 
derivative was induced to polymerize spontaneously by three different procedures of solvent 
removal to obtain three different samples of polybenzofulvene derivative poly-6-MOEG-9-T-BF3k 
that were carefully studied by SEC-MALS, NMR spectroscopy, and MALDI-TOF MS techniques (see 
below). In particular, one polymer sample (i.e., poly-6-MOEG-9-T-BF3k-FE) was obtained by the 
standard procedure consisting of the fast solvent (i.e., CHCl3) evaporation at reduced pressure into a 
rotary evaporator apparatus. The second sample (i.e., poly-6-MOEG-9-T-BF3k-SE) was obtained by 
slow evaporation of the solvent (i.e., CHCl3) at room temperature, whereas the third sample (i.e., 
poly-6-MOEG-9-T-BF3k-WA) was obtained by the addition of water to the monomer solution in 
acetonitrile, followed by the partial evaporation of the organic solvent promoted by a nitrogen 
stream. 
The effective spontaneous polymerization of this benzofulvene monomer in all the tested 
experimental conditions in the apparent absence of initiators or catalysts supported the efficiency of 
the recognition step, which we assumed to play a pivotal role in the “affinity polymerization” 
mechanism [12,13,24]. In particular, the spontaneous polymerization in the water environment 
suggested that the recognition step is operative also in the water dispersion. Interestingly, we 
assumed that the presence of MOEG-9 SC in benzofulvene monomer 6-MOEG-9-T-BF3k led to the 
formation of amphiphilic molecules, which could be capable in principle of self-assembling in water 
solutions to form micelles. The hydrophobic nature of the 3-phenylbenzofulvene moieties could 
drive the aggregation [39–41] leading to the exposition of the MOEG-9 SC to the water environment 
[42]. In this organization, the recognition process and the following spontaneous polymerization 
could occur inside the core of the micelles [12,13]. 
3.2. NMR Spectroscopy Studies 
The 1H NMR spectroscopic features of benzofulvene monomer 6-MOEG-9-T-BF3k were studied 
in different deuterated organic solvents, namely chloroform and acetonitrile (Figures 4 and 5). 
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Figure 4. Comparison of the 1H NMR spectra (500 MHz) of monomer 6-MOEG-9-T-BF3k acquired 
respectively in CDCl3 (bottom trace) and in CD3CN (top trace). 
 
Figure 5. Comparison of the 13C NMR spectra (125 MHz) of monomer 6-MOEG-9-T-BF3k acquired 
respectively in CDCl3 (bottom trace) and in CD3CN (top trace). 
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As expected, the NMR spectra of 6-MOEG-9-T-BF3k were dominated by the signals attributed 
to the MOEG-9 side chain (at around 3.5–3.6 ppm in the 1H NMR spectra and at around 70 ppm in 
the 13C NMR spectra). The comparison of the two spectra demonstrated the relatively limited 
dependence on the solvent system of both the chemical shift values of the signals and the 
dehydration process, confirming the full equivalence of CHCl3 and CH3CN in the preparation of this 
benzofulvene monomer. Thus, the chloroform solutions of the monomer were used for the 
spontaneous polymerization by solvent evaporation, whereas the acetonitrile solutions were used 
for transferring the benzofulvene monomer in the water environment. Accordingly, D2O was added 
to the NMR tube containing 6-MOEG-9-T-BF3k solution in CH3CN doubling the initial volume and 
the resulting mixture was concentrated by means of a gentle nitrogen stream to the initial volume. 
This procedure was repeated and we observed that the starting pale yellow solution gradually 
became a cloudy mixture, suggesting that the pale yellow benzofulvene monomer underwent 
spontaneous polymerization in the water environment. The 1H NMR experiments (Figure 6) 
performed during the transferring of the benzofulvene monomer in the water environment 
confirmed the occurrence of the spontaneous polymerization in the water dispersion. 
 
Figure 6. 1H NMR spectra performed during the transferring of the benzofulvene monomer 
6-MOEG-9-T-BF3k in the water environment. Comparison of 1H NMR spectrum of the benzofulvene 
monomer in CD3CN (bottom trace) with that of the same monomer after diluting (1:1) with D2O 
(middle trace) the initial monomer solution and after the partial evaporation of the organic solvent 
(top trace). 
The polymeric material (i.e., poly-6-MOEG-9-T-BF3k-WA) was extracted from the water 
environment with chloroform and, after purification by precipitation (see Materials and Methods for 
the details) its NMR spectra were compared with those of poly-6-MOEG-9-T-BF3k-FE (i.e., the 
sample obtained by the standard procedure consisting of the fast solvent evaporation at reduced 
pressure into a rotary evaporator apparatus) and of poly-6-MOEG-9-T-BF3k-SE (i.e., the sample 
obtained by slow evaporation of the solvent at room temperature (Figures 7 and 8)). 
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Figure 7. Comparison of the 1H NMR spectrum of monomer 6-MOEG-9-T-BF3k (500 MHz, CDCl3, 
top trace) with those of the corresponding polymers: poly-6-MOEG-9-T-BF3k-WA, 
poly-6-MOEG-9-T-BF3k-FE, and poly-6-MOEG-9-T-BF3k-SE. 
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Figure 8. Comparison of the 13C NMR spectrum of monomer 6-MOEG-9-T-BF3k (125 MHz, CDCl3, 
top trace) with those of the corresponding polymers: poly-6-MOEG-9-T-BF3k-WA, 
poly-6-MOEG-9-T-BF3k-FE, and poly-6-MOEG-9-T-BF3k-SE. 
As in the case of monomer 6-MOEG-9-T-BF3k, the 1H NMR spectra of poly-6-MOEG-9-T-BF3k 
were dominated by the signals at around 3.5–3.6 ppm attributed to the MOEG-9. However, the 
comparison of the spectra shown in Figure 7 clearly showed that the sharp signals of the monomer 
became broad in the spectra of the polymers with some up-field shift as already observed in similar 
polybenzofulvene derivatives. As expected, the aromatic region showed the presence of a single 
broad signal with a small, but significant shoulder at around 8 ppm attributed to the triazole 
hydrogen atom. 
The 13C NMR spectra (Figure 8) showed a higher resolution than that of the 1H NMR one, but as 
observed in similar PEGylated polybenzofulvene brushes [22–26], the MOEG-9 side chains showed a 
rather negative impact in the NMR features of these polymers (i.e., severe line broadening) and only 
the direct comparison between monomer and polymer allowed quite reliable analysis to be 
performed in terms of correspondence between the various peaks. In particular, the presence of 
broad peaks at around 49 and 57 ppm supported the retention of the spontaneous 
1,2-polymerization mechanism as already observed in related PEGylated polybenzofulvene brushes 
[22–26]. 
3.3. MALDI-TOF Mass Spectrometry Characterization 
The macromolecular structure of poly-6-MOEG-9-T-BF3k was investigated also by 
MALDI-TOF mass spectrometry. In particular, the MALDI-TOF mass spectrum of 
poly-6-MOEG-9-T-BF3k-FE (i.e., the sample obtained by the standard procedure consisting of the 
fast solvent evaporation at reduced pressure into a rotary evaporator apparatus, Figure 9) was 
obtained in linear mode by using 2,5-dihydroxybenzoic acid (DHBA) as the matrix. The best mass 
spectra in reflectron mode were recorded using DCTB 
(trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile) as a matrix, often in the 
presence of Li+, Na+ and K+ salts as doping agent. 
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Figure 9. Matrix assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrum of 
poly-6-MOEG-9-T-BF3k-FE (i.e., the sample obtained by the standard procedure consisting of the 
fast solvent evaporation at reduced pressure into a rotary evaporator apparatus). The inset displays 
an enlarged section of the mass spectrum recorded in reflectron mode using DCTB as matrix and 
CF3COOLi salt as doping agent. 
As expected, the spectrum showed the presence of families of peaks from m/z ~3000 up to m/z 
~7000 showing 754 Da transitions, which corresponded to the molar mass of the monomeric unit of 
poly-6-MOEG-9-T-BF3k (i.e., 753.8). The main peaks were assigned to the protonated ions of the 
expected oligomers terminated with hydrogens at both ends (Figure 9). The structure of the polymer 
chains was also confirmed by MALDI-TOF MS analysis in reflectron which gave more resolved mass 
peaks and in particular the isotopic distributions of the species composing the samples. The inset in 
Figure 9 shows the lithiated, sodiated and potassiated ions corresponding to the dimers ended with 
hydrogen at both ends. The mass spectrum of the poly-6-MOEG-9-T-BF3k-WA recorded in 
reflectron mode was very similar to that of poly-6-MOEG-9-T-BF3k-FE and presents in the mass 
range between 750 and 5000 Da the mass resolved peaks corresponding to the dimers, trimers, 
tetramers, pentamers and hexamers ended with hydrogen at both ends. On the contrary, very 
complex mass spectra were recorded by analyzing the poly-6-MOEG-9-T-BF3k-SE fraction soluble 
in CHCl3. Besides the peaks due to protonated ions of oligomers terminated with hydrogen, the 
mass spectra present other mass series corresponding to the oxidized species and to the species 
maybe formed by reaction of the biradicals with the solvent and or with the MOEG side chains. 
Therefore, the presence of these new species suggested that during the slow evaporation the 
biradicals can give cross-linking reactions forming polymer chains insoluble in the common organic 
solvents used to solubilize the the poly-6-MOEG-9-T-BF3k samples (i.e., CHCl3, THF, DMSO, DMF). 
This evidence supports that the better conditions to synthesize the poly-6-MOEG-9-T-BF3k samples 
occurs at very fast evaporation of the solvent (i.e., CHCl3). 
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3.4. Molecular Weight Distribution Characterization 
The molecular weight distribution in poly-6-MOEG-9-T-BF3k samples (i.e., 
poly-6-MOEG-9-T-BF3k-WA, poly-6-MOEG-9-T-BF3k-FE, and poly-6-MOEG-9-T-BF3k-SE) was 
analyzed by means of a SEC-MALS system with THF–DMF (8:2) containing 0.01 M LiBr as the 
mobile phase.  
Very interestingly, the results summarized in Table 1 proved that the MWD features of 
poly-6-MOEG-9-T-BF3k samples were affected by the polymerization conditions. In fact, the MWD 
of the sample obtained by the standard procedure consisting of the fast solvent evaporation at 
reduced pressure into a rotary evaporator apparatus (i.e., poly-6-MOEG-9-T-BF3k-FE) showed Mp 
and polydispersity index MW/Mn values in the same range observed for previously published PPBFB 
poly-6-MOEG-9-TM-BF3k and poly-6-MOEG-9-BF3k, which were included in Table 1 for 
comparative purposes [23–25].  
Table 1. Macromolecular features of the newly-synthesized poly-6-MOEG-9-T-BF3k samples in 
comparison with the ones shown by previously described poly-6-MOEG-9-TM-BF3k, and 
poly-6-MOEG-9-BF3k. 
Polymer  
Mp 
(kg/mol) a 
MW 
(kg/mol) b 
PDI c 
Rg 
(nm) d 
poly-6-MOEG-9-T-BF3k-SE 5.14 6.05 1.5 - 
poly-6-MOEG-9-T-BF3k-WA 63.8 73.4 2.1 19.0 
poly-6-MOEG-9-T-BF3k-FE 488 752 2.5 41.3 
poly-6-MOEG-9-TM-BF3k-GO e 484 821 8.9 33.6 
poly-6-MOEG-9-TM-BF3k-GT e 193 358 3.9 15.5 
poly-6-MOEG-9-BF3k 527 456 1.8 20.8 
a Mp: peak molecular weight; b Mw: weight-average molecular weight; c PDI: polydispersity index, PDI 
= Mw/Mn where Mn denotes the number-average molecular weight; d Rg: radius of gyration, which is 
the dimension of the macromolecules. e Poly-6-MOEG-9-TM-BF3k-GT sample was obtained by the 
grafting through approach, whereas poly-6-MOEG-9-TM-BF3k-GO was prepared by the grafting 
onto method [24,25]. 
On the other hand, the sample obtained by slow evaporation of the solvent at room temperature 
(i.e., poly-6-MOEG-9-T-BF3k-SE) showed a surprisingly low Mp value, which was around two 
orders of magnitude lower than the one shown by poly-6-MOEG-9-T-BF3k-SE. Accordingly, the 
polydispersity index MW/Mn value was also the lowest measured for these PPBFB derivatives. 
Moreover, the sample obtained by spontaneous polymerization in a water environment (i.e., 
poly-6-MOEG-9-T-BF3k-WA) showed intermediate MWD features.  
We assume that the slow evaporation of the solvent at room temperature (as in a typical 
crystallization procedure) induces 6-MOEG-9-T-BF3k monomers to aggregate slowly in columnar 
aggregates, which undergo spontaneous polymerization when a critical number of monomers are 
compacted to reach the critical stereo-electronic parameters for the establishment of the covalent 
bonds leading to the polymer backbone. The spontaneous polymerization was rapidly terminated 
by the interaction of the polymeric biradical species with the excess of the quenching ones (i.e., water 
molecules) present in the polymerization mixture. Thus, the macromolecules contained in 
poly-6-MOEG-9-T-BF3k-SE sample could be assumed to represent the true initiator species in the 
spontaneous polymerization of this benzofulvene monomer. These initiator species could develop 
into a polymer showing an intermediate molecular weight distribution, in the presence of a limited 
number of monomer molecules composing the micelles that are assumed to be involved in the 
formation of poly-6-MOEG-9-T-BF3k-WA sample. On the other hand, when a large number of 
monomer molecules are condensed in a small space and the quenching species are rare as during the 
fast solvent evaporation at reduced pressure into a rotary evaporator apparatus, the small initiator 
species could easily evolve into polybenzofulvene macromolecules (i.e., poly-6-MOEG-9-T-BF3k-FE) 
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showing a relatively high molecular weight and corresponding to an apparent plateau very similar 
in the related PPBFB derivatives reported in Table 1.  
Apart from the mechanistic considerations, these observations indicate a possible way to 
modulate the MWD of these PPBFB derivatives by spontaneous polymerization. 
3.5. Self-Aggregating Properties  
The ability of PPBFB derivative poly-6-MOEG-9-T-BF3k to generate supramolecular carriers 
spontaneously was evaluated by critical aggregation concentration (CAC) determinations (i.e., 
pyrene fluorescence analysis) and then by means of dynamic light scattering analysis and zeta 
potential measurements. In particular, the CAC value was calculated from the intersection of the 
regression lines obtained before and after the slope change (low and high concentration regions, 
Figure 10). Among the newly-synthesized PPBFB samples, only poly-6-MOEG-9-T-BF3k-FE showed 
a CAC value between 0.001 and 0.05 mg/mL. Interestingly, the variations of I373/I384 intensity ratio 
obtained from pyrene emission spectra were in accordance with the stabilization of the surface Z 
potential values, correlated to the generation of a homogeneous self-aggregating nanoparticles 
population. 
 
Figure 10. I373/I384 intensity ratio obtained from pyrene emission spectra in the presence of 
poly-6-MOEG-9-T-BF3k-FE (blue curve) and Z-potential values (orange curve) as a function of 
polymer concentration. 
Thus, DLS analysis was performed on poly-6-MOEG-9-T-BF3k-FE samples, which were 
dispersed in ultrapure water at room temperature at concentration values higher than the found 
CMC one. DLS measurements were performed after 2 and 30 days and no mean variation in size was 
observed during this time frame (Table 2). 
Table 2. Dynamic light scattering (DLS) results obtained with poly-6-MOEG-9-T-BF3k-FE in 
ultrapure water at 25 °C (reported data are those recorded after 2 days) compared with those 
obtained with parent PPBFB derivative poly-6-MOEG-9-TM-BF3k samples. 
Polymer Sample 
Za 
(nm ± SD) 
PDI ± SD 
Zp 
(mV ± SD) 
poly-6-MOEG-9-T-BF3k-FE 166 ± 15 0.24 ± 0.02 −26.0 ± 7.2 
poly-6-MOEG-9-TM-BF3k-GT a 245 ± 25 0.43 ± 0.04 - 
poly-6-MOEG-9-TM-BF3k-GO a 57 ± 6 0.38 ± 0.04 −7.23 ± 1.5 
a Poly-6-MOEG-9-TM-BF3k-GT sample was obtained by the grafting through approach, whereas 
poly-6-MOEG-9-TM-BF3k-GO was prepared by the grafting onto method [24,25]. 
The results advocated that poly-6-MOEG-9-T-BF3k-FE was inclined to produce water-soluble 
nanoparticles showing dimensions around 166 nm in agreement with the results obtained with 
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parent PPBFB derivative poly-6-MOEG-9-TM-BF3k samples [24,25]. In particular, 
poly-6-MOEG-9-T-BF3k-FE derivative generated in water two homogeneous populations (Figure 
11), which, on the bases of the apparent dimensions, were assumed to be isolated macromolecules 
(diameter around 20 nm) and supra-macromolecular aggregates (diameter around 150 nm).  
 
Figure 11. DLS size distribution histograms of poly-6-MOEG-9-T-BF3k-FE dispersions in ultrapure 
water. 
3.6. Transmission Electron Microscopy Studies 
The self-aggregating features of poly-6-MOEG-9-T-BF3k-FE were substantiated by the results 
of TEM analysis. In particular, a sample (~2 mg) of the polymer was treated with water (0.5 mL) at 
room temperature in static conditions to produce the swelling of the polymer in few minutes to form 
a transparent hydrogel, which was expanded by the progressive swelling up the formation of an 
opalescent dispersion after 1 h. After equilibration at room temperature for two weeks, the nearly 
transparent dispersion was analyzed by transmission electron microscopy (TEM) with negative 
staining with uranyl acetate. The analysis of TEM images suggested the propensity of 
poly-6-MOEG-9-T-BF3k-FE to generate spherical objects showing dimensions in the range of 20–200 
nm (Figure 12) in agreement with the assumption that isolated macromolecules (~20 nm) were liable 
to self-assemble into supramolecular entities showing greater dimensions. 
 
Figure 12. Structure of macromolecular aggregates found by TEM analysis of 
poly-6-MOEG-9-T-BF3k-FE solutions in water. The scale bar corresponds to 1 μm in the left panel 
and 200 nm in the right panel. 
3.7. Photophysical Characterization 
The development of efficient drug delivery systems requires the understanding of their 
interactions with the biological systems (e.g., cell/tissue penetration, interaction with possible 
targets, metabolism). In general, the emission properties of both small molecules or polymeric 
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materials are largely exploited in biological investigations as well as in some clinical applications. In 
particular, the visible portion of the radiative spectrum (400–800 nm) is widely used in fluorescence 
microscopy, which represents a valuable tool for the investigation of many functional aspects of 
drug delivery systems [43]. The polybenzofulvene derivatives represent interesting π-stacked 
fluorescent polymers capable of emitting visible light [14,18,23,24]. We assumed that in 
poly-6-MOEG-9-T-BF3k-FE, the insertion of a triazole ring directly connected to the 3-phenylindene 
structure can increase conjugation in the repeating unit and therefore improve the optical features 
useful in fluorescence microscopy studies. Thus, the photophysical features of PPBFB derivative 
poly-6-MOEG-9-T-BF3k-FE were studied both in solution and in the solid state (i.e., gummy solid) 
(Figure 13). 
 
Figure 13. Normalized absorption and emission spectra of poly-6-MOEG-9-T-BF3k-FE in 
dichloromethane solution (top) and in the solid state (bottom). Optical absorption (black solid line), 
emission excitation profiles (λem = 470 nm, dotted blue lines) and emission spectra (λex = 330 nm, blue 
solid line; λex = 390 nm, black solid line; λex = 420 nm, green solid line; λex = 490 nm, red solid line). 
The diluted dichloromethane solution displays two absorption bands at about 315 and 250 nm 
with a blue emission (λem = 470 nm) showing a quantum yield (QY) of 4%. The emission in the solid 
state is characterized by a very similar blue broad band, peaked at 470 nm, that displays a higher QY 
of 17% (λex = 380 nm). Interestingly, by selective excitation at longer wavelengths, a red-shift of the 
emission band is detected at 490 nm (λex = 420 nm), down to 555 nm (λex = 490 nm). This behavior 
indicates that in the solid state the polymeric chains display different aggregation motives, 
providing a wide emission in the blue-green visible region. Interesting, the absorption/emission 
features and the significant QY of poly-6-MOEG-9-T-BF3k-FE can be considered compatible with its 
employment in a fluorescence microscopy apparatus using standard filters for fluorescence stain 
DAPI (4′-6-diamidino-2-phenylindole) [44,45]. 
3.8. Biocompatibility Evaluation 
The potential cytotoxicity features of PPBFB derivative poly-6-MOEG-9-T-BF3k-FE were 
evaluated both on human colon adenocarcinoma HCT116 cells and on normal human bronchial 
epithelial (16HBE) cell lines, the latter being widely used to model barrier function of the airway 
epithelium, after incubation for 24 and 48 h. The tested concentrations ranged from 0.005 to 0.5 
mg/mL, and the results (Figure 14) demonstrated that, for both incubation times, 24 h and 48 h, the 
cell viability was always comparable to the control cells. Even on normal bronchial epithelial cells, 
notoriously very sensitive to xenobiotic agents and largely used to test biocompatibility on normal 
human cells [46–48], the tested polymer resulted to be sufficiently biocompatible with the exception 
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of the highest concentration of 0.5 mg/mL. Therefore, poly-6-MOEG-9-T-BF3k-FE derivative was 
proven to be clearly cytocompatible at incubation concentrations below 0.5 mg/mL; actually, below 
this value cell viability is always above 80%, even for normal cells. This result supports its potential 
employment in nanoencapsulation and delivery of drug molecules.  
 
Figure 14. Cell viability % (tetrazolium salt (MTS) assay) of poly-6-MOEG-9-T-BF3k-FE on human 
colon cancer cells HCT116 (panel A) and normal human bronchial epithelial cells 16HBE (panel B) 
cells, after 24 h and 48 h of incubation at concentrations of 0.005, 0.01, 0.03, 0.1 and 0.5 mg/mL. 
4. Conclusions 
A novel PEGylated polybenzofulvene brush (i.e., poly-6-MOEG-9-T-BF3k) was prepared by 
means of a “grafting through” approach in which the polybenzofulvene backbone was built by 
spontaneous polymerization of benzofulvene macromonomer 6-MOEG-9-T-BF3k bearing a 
MOEG-9 side chain linked to position 6 of the 3-phenylindene scaffold by means of a triazole 
heterocycle. The spontaneous polymerization of the benzofulvene macromonomer was assayed in 
three different procedures of solvent removal and the successful spontaneous polymerization in all 
the experimental conditions supported the efficiency of the recognition step at the base of the 
assumed “affinity polymerization” mechanism. Very intriguingly, the spontaneous polymerization 
occurred also in a water environment, where benzofulvene monomer 6-MOEG-9-T-BF3k was 
assumed to self-assemble to form micelles. The three polymer samples were characterized by 
SEC-MALS, NMR spectroscopy, and MALDI-TOF MS techniques, and the differences observed in 
the MWD features suggested the spontaneous polymerization could advance through the formation 
of oligomeric initiatory species, which evolve in macromolecules showing different polymerization 
degrees depending on the presence of monomers molecules and/or quenching species.  
The high molecular weight poly-6-MOEG-9-T-BF3k was then characterized from the point of 
view of its aggregation liability and potential biocompatibility. In particular, pyrene fluorescence 
analysis suggested a CAC value between 0.01 and 0.05 mg/mL, and DLS studies showed the 
presence in the water dispersions of two homogeneous populations: one showing dimensions 
around 20 nm and the other showing diameters around 150 nm. This result was confirmed by TEM 
analysis, which showed the presence of spherical objects showing dimensions in the range of 20–200 
nm. On the basis of their apparent dimensions, these objects were assumed to be isolated 
macromolecules and supra-macromolecular aggregates. Interestingly, the cytocompatibility shown 
by poly-6-MOEG-9-T-BF3k-FE at concentrations below 0.5 mg/mL, taken together with its 
aggregation features, supports its potential employment in nanoencapsulation and delivery of drug 
molecules. Moreover, the emission features of this PPBFB derivative constituted an added value 
owing to the possibility of monitoring the biodistribution by fluorescence microscopy techniques.  
In particular, the property of the polymer of spontaneously forming polymeric micelles in 
water makes it an ideal candidate for the encapsulation of drugs that are low soluble in water and 
with a high therapeutic index, e.g., many anticancer drugs. Furthermore, the colloidal dimensions of 
the nanosystems it constitutes should, as is known, allow an accumulation into tumor masses thanks 
to the well-known enhanced permeation and retention effect, without excluding the possibility of 
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monitoring the accumulation of the encapsulated drug by exploiting the fluorescence emission 
properties of the polymer. 
Supplementary Materials: The following are available online at www.mdpi.com/1999-4923/11/9/444/s1, the CIF 
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